PRN Anxiety Dosing for an 87-Year-Old with eGFR 32 mL/min
For this 87-year-old patient with moderate-to-severe renal impairment (eGFR ~32 mL/min), prescribe lorazepam 0.25 mg orally every 4-6 hours as needed for acute anxiety, with a maximum of 1 mg in 24 hours.
Rationale and Dosing Algorithm
The most recent and relevant guideline evidence comes from the 2020 NICE COVID-19 guidelines 1, which specifically addresses anxiety management in elderly and debilitated patients. This guideline explicitly recommends reducing lorazepam doses to 0.25-0.5 mg in elderly or debilitated patients with a maximum of 2 mg in 24 hours 1. However, given your patient's additional renal impairment (eGFR 32 mL/min), further dose reduction is warranted.
Why Lorazepam Over Other Benzodiazepines
- Lorazepam is the preferred benzodiazepine because it undergoes hepatic glucuronidation rather than oxidative metabolism, making it safer in renal impairment 2
- Midazolam should be avoided in this patient despite being mentioned in guidelines, as recent 2025 evidence shows midazolam poses elevated risk of serious adverse events in older adults without gains in clinical efficacy 3
- The 2018 ESMO guidelines 4 recommend lorazepam 0.25-0.5 mg for elderly or frail patients, which aligns with your patient profile
Specific Dosing Adjustments for Renal Impairment
While lorazepam itself requires no formal dose adjustment for renal impairment 2, the combination of:
- Advanced age (87 years)
- Moderate-to-severe CKD (eGFR 32 mL/min)
- Increased fall risk in elderly patients 4
Justifies starting at the lowest effective dose: 0.25 mg PRN, with a conservative 24-hour maximum of 1 mg rather than the 2 mg maximum cited for general elderly populations.
Route of Administration
- Oral route is strongly preferred - Recent 2025 evidence demonstrates that oral medications, particularly in older adults, have the best safety profile with significantly lower adverse event rates compared to IV or IM administration 3
- Lorazepam tablets can be used sublingually (off-label) if swallowing is difficult 1
- Only consider subcutaneous or IV routes if the patient is unable to swallow
Critical Safety Considerations
Avoid These Common Pitfalls:
Do not use midazolam - Despite guideline mentions, 2025 data shows excessive adverse events in older adults 3
Monitor for paradoxical agitation - Benzodiazepines can cause delirium, drowsiness, and paradoxical agitation in elderly patients 4
Assess fall risk - The 2018 ESMO guidelines explicitly warn of increased fall risk with benzodiazepines in older adults 4
Watch for dose-response toxicity - The 2025 geriatric emergency guidelines observed increased adverse events with escalating lorazepam doses 3
Avoid combining with antipsychotics - If co-administered with antipsychotics, reduce lorazepam to 0.25 mg due to risk of oversedation and respiratory depression 4
Before Prescribing:
- Address reversible causes first: hypoxia, urinary retention, constipation, pain 1
- Explore patient concerns and ensure adequate communication 1
- Check for contraindications: severe pulmonary insufficiency, severe liver disease, myasthenia gravis 4
Monitoring and Documentation
- Document specific indication for each PRN dose (e.g., "acute anxiety with agitation") - only 62% of administered PRN psychotropics have documented indications 5
- Reassess need after each administration
- Consider scheduled dosing only if needed more than twice daily, but use for shortest duration possible 4
- Monitor for signs of accumulation: excessive sedation, confusion, ataxia
Alternative if Lorazepam Fails or Is Contraindicated
If anxiety persists or lorazepam is not tolerated, consider quetiapine 12.5-25 mg orally (half the standard starting dose due to renal impairment and age) 4. The 2025 geriatric data shows quetiapine has the best safety profile among antipsychotics in older adults 3, though it requires dose reduction in elderly patients and those with hepatic impairment 4.